Electrical stimulation uses electrotherapy for treating spinal injuries and muscle weakness associated with neurological disorders. It has property to activate electrical impulse and transmit signal to electrodes of device, which causes depolarization and in turn reduces pain and improves muscle strength. Different types of electrical stimulation devices are designed to treat various diseases such as pain management, obesity, and others.
Increasing prevalence of neurological disorders, which in turn causes muscle weakness is expected to propel electrical stimulation devices market growth. According to Neurology Today Journal, November 2017, neurological diseases are the world’s largest cause of disability-adjusted life years (DALYs) and an estimated 9.5 million deaths were due to the condition in 2015. Moreover, advantages of electrical stimulation devices of pain management in preoperative and postoperative surgery procedures are expected to boost the market growth.
- This report provides in-depth analysis of the electrical stimulation devices market and provides market size (USD Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global electrical stimulation devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Boston Scientific Neuromodulation Corporation, BTL Industries, Inc., Cyberonics, Inc., DJO Global, Inc., Medtronic plc., Nevro Corporation., NeuroMetrix, Inc., St. Jude Medical, Inc., Uroplasty, Inc. (Cogentix Medical), and Zynex, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
- The global electrical stimulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the electrical stimulation devices market
-
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Vagus Nerve Stimulation Devices
- Sacral Nerve Stimulation Devices
- Gastric Electric Stimulation Devices
- Transcutaneous electrical nerve stimulation Devices
- Neuromuscular Electrical Stimulation Devices
- Cranial Electrical Stimulation Devices
- Other Electrical Stimulation Devices
-
- Pain Management
- Neurological and Movement Disorder Management
- Musculoskeletal Disorder Management
- Metabolism & GIT Management
- Incontinence Management
- Others
-
- Hospitals
- Specialty Clinics
- Ambulatory Centers
- Others
-
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
-
- Boston Scientific Corporation
- BTL Industries, Inc.
- Cyberonics, Inc.
- DJO Global, Inc.
- Medtronic plc.
- Nevro Corporation.
- NeuroMetrix, Inc.
- Jude Medical, Inc.
- Uroplasty, Inc. (Cogentix Medical)
- Zynex, Inc.
